$PTCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PTC THERAPEUTICS, INC.. Get notifications about new insider transactions in PTC THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 17 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 55.48 | 25,599 | 1,420,233 | 80,486 | 106.1 K to 80.5 K (-24.13 %) |
Jul 17 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 50,000 | 542,500 | 106,085 | 56.1 K to 106.1 K (+89.15 %) |
Jul 17 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 55.94 | 24,403 | 1,365,177 | 56,085 | 80.5 K to 56.1 K (-30.32 %) |
Jul 17 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 55.48 | 25,597 | 1,419,994 | 80,488 | 106.1 K to 80.5 K (-24.13 %) |
Jul 17 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 50,000 | 542,500 | 106,085 | 56.1 K to 106.1 K (+89.15 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 17,500 | 315,175 | 26,250 | |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 13,125 | 147,394 | 6,563 | |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.73 | 100 | 5,573 | 39,724 | 39.8 K to 39.7 K (-0.25 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.24 | 3,675 | 203,011 | 39,824 | 43.5 K to 39.8 K (-8.45 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.20 | 600 | 32,517 | 43,499 | 44.1 K to 43.5 K (-1.36 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.74 | 400 | 22,295 | 44,099 | 44.5 K to 44.1 K (-0.90 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.23 | 7,350 | 405,955 | 44,499 | 51.8 K to 44.5 K (-14.18 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.20 | 1,000 | 54,202 | 51,849 | 52.8 K to 51.8 K (-1.89 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.26 | 3,775 | 208,591 | 52,849 | 56.6 K to 52.8 K (-6.67 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.20 | 600 | 32,517 | 56,624 | 57.2 K to 56.6 K (-1.05 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 17,500 | 315,175 | 57,224 | 39.7 K to 57.2 K (+44.05 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.73 | 200 | 11,146 | 39,724 | 39.9 K to 39.7 K (-0.50 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.23 | 4,301 | 237,536 | 39,924 | 44.2 K to 39.9 K (-9.73 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.18 | 626 | 33,916 | 44,225 | 44.9 K to 44.2 K (-1.40 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.24 | 2,881 | 159,144 | 44,851 | 47.7 K to 44.9 K (-6.04 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.15 | 400 | 21,659 | 47,732 | 48.1 K to 47.7 K (-0.83 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.73 | 100 | 5,573 | 48,132 | 48.2 K to 48.1 K (-0.21 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.22 | 2,824 | 155,953 | 48,232 | 51.1 K to 48.2 K (-5.53 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.11 | 357 | 19,317 | 51,056 | 51.4 K to 51.1 K (-0.69 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 55.31 | 962 | 53,205 | 51,413 | 52.4 K to 51.4 K (-1.84 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 54.70 | 474 | 25,927 | 52,375 | 52.8 K to 52.4 K (-0.90 %) |
Jul 09 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 13,125 | 147,394 | 52,849 | 39.7 K to 52.8 K (+33.04 %) |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 18.01 | 2,500 | 45,025 | 17,855 | |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 11.23 | 788 | 8,849 | 1,575 | |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 54.40 | 500 | 27,202 | 9,562 | 10.1 K to 9.6 K (-4.97 %) |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 53.81 | 2,000 | 107,614 | 10,062 | 12.1 K to 10.1 K (-16.58 %) |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 18.01 | 2,500 | 45,025 | 12,062 | 9.6 K to 12.1 K (+26.15 %) |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 52.98 | 788 | 41,748 | 9,562 | 10.4 K to 9.6 K (-7.61 %) |
Jul 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 11.23 | 788 | 8,849 | 10,350 | 9.6 K to 10.4 K (+8.24 %) |
Jul 01 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 52.50 | 2,581 | 135,503 | 13,610 | 16.2 K to 13.6 K (-15.94 %) |
Jun 12 2020 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Sell | S | 48.36 | 364 | 17,603 | 26,286 | 26.7 K to 26.3 K (-1.37 %) |
May 20 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 6,284 | 68,181 | 236,818 | |
May 20 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.12 | 6,284 | 314,979 | 56,085 | 62.4 K to 56.1 K (-10.08 %) |
May 20 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 6,284 | 68,181 | 62,369 | 56.1 K to 62.4 K (+11.20 %) |
May 07 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 109,928 | 1,192,719 | 243,102 | |
May 07 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 51.01 | 1,985 | 101,253 | 56,085 | 58.1 K to 56.1 K (-3.42 %) |
May 07 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.33 | 107,943 | 5,432,339 | 58,070 | 166 K to 58.1 K (-65.02 %) |
May 07 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 109,928 | 1,192,719 | 166,013 | 56.1 K to 166 K (+196.00 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 18.01 | 2,145 | 38,631 | 20,355 | |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 50.00 | 2,145 | 107,250 | 9,304 | 11.4 K to 9.3 K (-18.74 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 18.01 | 2,145 | 38,631 | 11,449 | 9.3 K to 11.4 K (+23.05 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | M | 10.85 | 17,900 | 194,215 | 43,000 | |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | M | 10.85 | 2,100 | 22,785 | 60,900 | |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 52.16 | 100 | 5,216 | 8,498 | 8.6 K to 8.5 K (-1.16 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 51.41 | 9,653 | 496,299 | 8,598 | 18.3 K to 8.6 K (-52.89 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 50.58 | 8,147 | 412,043 | 18,251 | 26.4 K to 18.3 K (-30.86 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Buy | M | 10.85 | 17,900 | 194,215 | 26,398 | 8.5 K to 26.4 K (+210.64 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 50.16 | 2,100 | 105,332 | 8,498 | 10.6 K to 8.5 K (-19.82 %) |
Apr 21 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Buy | M | 10.85 | 2,100 | 22,785 | 10,598 | 8.5 K to 10.6 K (+24.71 %) |
Apr 17 2020 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Option Exercise | A | 47.49 | 50,000 | 2,374,500 | 50,000 | |
Apr 17 2020 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Apr 17 2020 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Option Exercise | A | 47.49 | 50,000 | 2,374,500 | 50,000 | |
Apr 17 2020 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Grant | A | 0.00 | 10,000 | 0 | 33,841 | 23.8 K to 33.8 K (+41.94 %) |
Apr 07 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 11.23 | 787 | 8,838 | 2,363 | |
Apr 07 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 44.31 | 787 | 34,872 | 9,304 | 10.1 K to 9.3 K (-7.80 %) |
Apr 07 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 11.23 | 787 | 8,838 | 10,091 | 9.3 K to 10.1 K (+8.46 %) |
Mar 18 2020 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Buy | P | 32.48 | 10,000 | 324,846 | 100,066 | 90.1 K to 100.1 K (+11.10 %) |
Feb 12 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | M | 12.92 | 625 | 8,075 | 3,125 | |
Feb 12 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 53.92 | 625 | 33,700 | 6,744 | 7.4 K to 6.7 K (-8.48 %) |
Feb 12 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Buy | M | 12.92 | 625 | 8,075 | 7,369 | 6.7 K to 7.4 K (+9.27 %) |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 10.85 | 3,102 | 33,657 | 0 | |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 10.85 | 46,898 | 508,843 | 0 | |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 55.00 | 4,040 | 222,200 | 1,912 | 6 K to 1.9 K (-67.88 %) |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 55.00 | 405 | 22,275 | 5,952 | 6.4 K to 6 K (-6.37 %) |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 55.00 | 3,102 | 170,610 | 27,089 | 30.2 K to 27.1 K (-10.27 %) |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 10.85 | 3,102 | 33,657 | 30,191 | 27.1 K to 30.2 K (+11.45 %) |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 55.00 | 46,898 | 2,579,390 | 27,089 | 74 K to 27.1 K (-63.39 %) |
Feb 07 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 10.85 | 46,898 | 508,843 | 73,987 | 27.1 K to 74 K (+173.13 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 51.16 | 59,500 | 3,044,020 | 59,500 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Grant | A | 0.00 | 10,200 | 0 | 39,724 | 29.5 K to 39.7 K (+34.55 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | A | 51.16 | 64,250 | 3,287,030 | 64,250 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Grant | A | 0.00 | 9,300 | 0 | 16,191 | 6.9 K to 16.2 K (+134.96 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | A | 51.16 | 23,800 | 1,217,608 | 23,800 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Grant | A | 0.00 | 4,080 | 0 | 9,304 | 5.2 K to 9.3 K (+78.10 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 51.16 | 28,600 | 1,463,176 | 28,600 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 51.16 | 192,500 | 9,848,300 | 192,500 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 4,855 | 0 | 22,957 | 18.1 K to 23 K (+26.82 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 33,000 | 0 | 56,085 | 23.1 K to 56.1 K (+142.95 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | A | 51.16 | 69,500 | 3,555,620 | 69,500 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Grant | A | 0.00 | 370 | 0 | 6,357 | 6 K to 6.4 K (+6.18 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Grant | A | 0.00 | 10,200 | 0 | 27,089 | 16.9 K to 27.1 K (+60.39 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 51.16 | 20,000 | 1,023,200 | 20,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Grant | A | 0.00 | 3,300 | 0 | 90,066 | 86.8 K to 90.1 K (+3.80 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Grant | A | 0.00 | 1,650 | 0 | 8,498 | 6.8 K to 8.5 K (+24.09 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 51.16 | 4,170 | 213,337 | 4,170 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 51.16 | 93,500 | 4,783,460 | 93,500 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Grant | A | 0.00 | 1,670 | 0 | 6,744 | 5.1 K to 6.7 K (+32.91 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Grant | A | 0.00 | 12,600 | 0 | 50,097 | 37.5 K to 50.1 K (+33.60 %) |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 51.16 | 10,000 | 511,600 | 10,000 | |
Jan 31 2020 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Grant | A | 0.00 | 1,650 | 0 | 26,650 | 25 K to 26.7 K (+6.60 %) |
Jan 27 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 53.25 | 330 | 17,572 | 6,891 | 7.2 K to 6.9 K (-4.57 %) |
Jan 27 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 53.25 | 423 | 22,523 | 18,102 | 18.5 K to 18.1 K (-2.28 %) |
Jan 27 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 53.25 | 46 | 2,449 | 5,987 | 6 K to 6 K (-0.76 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 48.17 | 86 | 4,142 | 5,228 | 5.3 K to 5.2 K (-1.62 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Gift | G | 0.00 | 1,000 | 0 | 37,497 | 38.5 K to 37.5 K (-2.60 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 18.01 | 7,500 | 135,075 | 22,500 | |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 13.10 | 6,250 | 81,875 | 0 | |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 50.03 | 7,500 | 375,233 | 5,224 | 12.7 K to 5.2 K (-58.94 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 18.01 | 7,500 | 135,075 | 12,724 | 5.2 K to 12.7 K (+143.57 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 50.00 | 6,250 | 312,500 | 5,224 | 11.5 K to 5.2 K (-54.47 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 13.10 | 6,250 | 81,875 | 11,474 | 5.2 K to 11.5 K (+119.64 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 48.17 | 360 | 17,340 | 5,224 | 5.6 K to 5.2 K (-6.45 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 49.62 | 59 | 2,928 | 6,033 | 6.1 K to 6 K (-0.97 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 48.17 | 57 | 2,746 | 6,092 | 6.1 K to 6.1 K (-0.93 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 48.17 | 70 | 3,372 | 6,149 | 6.2 K to 6.1 K (-1.13 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 48.17 | 507 | 24,421 | 16,889 | 17.4 K to 16.9 K (-2.91 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 48.17 | 359 | 17,292 | 18,525 | 18.9 K to 18.5 K (-1.90 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 48.17 | 439 | 21,146 | 18,884 | 19.3 K to 18.9 K (-2.27 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 48.17 | 1,797 | 86,558 | 23,085 | 24.9 K to 23.1 K (-7.22 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 49.62 | 63 | 3,126 | 7,221 | 7.3 K to 7.2 K (-0.86 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 48.17 | 200 | 9,634 | 7,284 | 7.5 K to 7.3 K (-2.67 %) |
Jan 08 2020 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 48.17 | 121 | 5,828 | 7,484 | 7.6 K to 7.5 K (-1.59 %) |
Jan 06 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 11.23 | 788 | 8,849 | 3,150 | |
Jan 06 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 11.23 | 2,362 | 26,525 | 3,938 | |
Jan 06 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 47.42 | 788 | 37,367 | 5,584 | 6.4 K to 5.6 K (-12.37 %) |
Jan 06 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 11.23 | 788 | 8,849 | 6,372 | 5.6 K to 6.4 K (+14.11 %) |
Jan 06 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 47.89 | 2,362 | 113,111 | 5,584 | 7.9 K to 5.6 K (-29.73 %) |
Jan 06 2020 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 11.23 | 2,362 | 26,525 | 7,946 | 5.6 K to 7.9 K (+42.30 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | M | 12.92 | 6,250 | 80,750 | 3,750 | |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | M | 18.01 | 30,000 | 540,300 | 45,000 | |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | M | 11.23 | 15,881 | 178,344 | 7,219 | |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | M | 12.53 | 30,000 | 375,900 | 0 | |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 48.80 | 6,250 | 305,000 | 5,038 | 11.3 K to 5 K (-55.37 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Buy | M | 12.92 | 6,250 | 80,750 | 11,288 | 5 K to 11.3 K (+124.06 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 49.19 | 18,668 | 918,279 | 38,221 | 56.9 K to 38.2 K (-32.81 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 48.43 | 11,332 | 548,820 | 56,889 | 68.2 K to 56.9 K (-16.61 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Buy | M | 18.01 | 30,000 | 540,300 | 68,221 | 38.2 K to 68.2 K (+78.49 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 49.32 | 7,004 | 345,430 | 38,221 | 45.2 K to 38.2 K (-15.49 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 48.58 | 8,877 | 431,245 | 45,225 | 54.1 K to 45.2 K (-16.41 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Buy | M | 11.23 | 15,881 | 178,344 | 54,102 | 38.2 K to 54.1 K (+41.55 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 49.14 | 21,271 | 1,045,257 | 38,221 | 59.5 K to 38.2 K (-35.75 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 48.32 | 8,729 | 421,794 | 59,492 | 68.2 K to 59.5 K (-12.80 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Buy | M | 12.53 | 30,000 | 375,900 | 68,221 | 38.2 K to 68.2 K (+78.49 %) |
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 49.14 | 14,814 | 727,975 | 38,221 | 53 K to 38.2 K (-27.93 %) |